癌胚抗原启动子控制基因靶向表达研究

目的 构建由癌胚抗原(CEA)启动子控制报道基因增强型绿色荧光蛋白(EGFP)表达的重组表达质粒CMVE-pCEA-IRES-EGFP.了解CEA启动子靶向驱动的含目的基因的重组质粒的效率.方法 构建重组质粒CMVE-pCEA-IRES-EGFP,以PCR,DNA测序及酶切进行鉴定.通过脂质体介导重组质粒CMVE-pCEA-IRES-EGFP体外分别转染A549细胞(CEA阳性)和16HBE(CEA阴性)细胞,进行绿色荧光蛋白检测分析基因表达的靶向性.结果 CMVE-pCEA-IRES-EGFP分别用VSP Ⅰ,VSP Ⅰ/Nhe Ⅰ酶切后电泳分别出现大小约405 bp,372 bp和4110 bp的片断,与预计各片断大小相符.以CMVE-pCEA-IRES-EGFP为模板PCR扩增得到CMV和CEA片段,分别连于T载体(pMD18-T)并测序,结果正确.嵌合启动子CMVE-pCEA能特异地驱动下游报告基因在CEA阳性肺癌细胞株绿色荧光表达阳性,而CEA阴性细胞株16HBE表达阴性.结论 成功构建了嵌合启动子CMVE-pCEA驱动的CMVE-pCEA-IRES-EGFP重组质粒,并能在转染的CEA阳性细胞株中表达,为靶向启动双基因表达载体构件提供了实验依据.     

氯化钴化学模拟低氧对肿瘤细胞增殖及凋亡的影响

目的 观察氯化钴(CoCl2)对体外培养的肿瘤细胞增殖和凋亡的影响,探讨合理的体外化学模拟低氧模式.方法 (1)MTY方法和流式细胞术检测不同浓度CoO:,在相应时间内对A549和HeLa细胞活力以及增殖和凋亡的影响.(2)免疫印迹测定HIE--la和凋亡蛋白的表达.结果 (1)CoCl:(≤200 p,mol/L)在24 h内对肿瘤细胞活力影响较轻,增加浓度或延长处理时间明显降低细胞活力.(2)CoCl2(200 l～mot/L)引起细胞早期凋亡.增加浓度(800 p,mol/L)导致晚期凋亡和坏死.(3)CoCl2(200 panol/L)诱导两种肿瘤细胞HIF.4a上调,24 h达高峰(P相似文献   

河北汉族人群四个Y短串联重复序列基因座遗传多态性

目的调查Y染色体特异基因座DYS438、DYS439、GATAA7.1、GATAA7.2的遗传多态性在河北汉族人群中的分布。方法应用聚合酶链反应及8%变性聚丙烯酰胺凝胶电泳分离扩增产物结合银染显带技术,对DYS438、DYS439、GATAA7.1、GATAA7.2基因座进行调查。结果DYS438、DYS439、GATAA7.1、GATAA7.2基因座分别检出4、5、5、4种等位基因,基因频率分布分别为0.0359～0.6587、0.0179～0.4107、0.0122～0.4146、0.0476～0.5238,个人识别率分别为0.5121、0.6811、0.6679和0.6327;上述4个基因座组成的单倍型在164名无关男性中共观察到70种,其中有36种仅出现一次,单倍型的个人识别机率达0.9480,家系调查符合单倍型父系遗传方式。结论DYS438、DYS439、GATAA7.1、GATAA7.2基因座个人识别机率高,属较高鉴别能力的遗传标记系统,且具有明显的人群分布差异,在法医学及人类遗传学研究中具有重要的应用价值。     

氟烷和七氟醚对缺血心肌功能和代谢及Ca2+-ATP酶活性的影响

目的: 研究氟烷、七氟醚(1.5MAC)对缺血心肌的影响。方法: 应用离体大鼠心脏Langendorff逆行灌注模型研究氟烷、七氟醚对心肌缺血前心率(HR)、左室舒张末期压力(LVEDP)、左室发展压(LVDP)、左室压力升高速率(+dp/dt)、左室压力下降速率(-dp/dt)和冠脉流量(CF)的影响,测定缺血前、缺血10min、缺血25min3个不同时间的心肌ATP含量、Ca²⁺-ATP酶活性,同时记录缺血间期左室内压的变化情况。结果: 七氟醚显著增加正常离体心脏的CF,氟烷、七氟醚均不同程度地抑制心肌收缩功能和Ca²⁺-ATP酶活性,能够增加正常心肌的能量贮备。缺血10min时,二药能够减缓心肌ATP含量及Ca²⁺-ATP酶活性的下降,氟烷的作用比较明显。缺血间期,氟烷明显推迟缺血性挛缩的起始时间,降低挛缩幅度。结论: 氟烷的抗缺血损伤作用优于七氟醚,延缓缺血期心肌ATP含量及Ca²⁺-ATP酶活性的下降可能是氟烷抗缺血损伤作用的重要机制之一。     

Applications of the pulsatile flow versatile ECLS: in vivo studies

INTRODUCTION: T-PLS (Twin-Pulse Life Support) is the first commercial pulsatile ECLS (Extra Corporeal Life Support) device (1). The dual sac structure of T-PLS can effectively reduce high membrane oxygenator inlet pressure and hemolysis. To verify both the use of T-PLS for ECLS and the advantages of T-PLS, we tested various models. METHOD AND RESULTS: In the partial CPB (cardio pulmonary bypass) model (swine), T-PLS (N = 6), and Biopump (N = 2), a single pulsatile pump (N = 2), were compared. In the case of single pulsatile flow, during pump systole, pressure increased to 700 - 800 mmHg at the inlet port of the membrane oxygenator. fHb, a hemolysis measurement value, was about 80 mg/dL at 3 hours. On the contrary, because of T-PLS's dual sac system, the pressure of T-PLS had a maximum value of about 250 mmHg and fHb was similar to that of the commercial centrifugal pumps. In the total CPB model (bovine, N = 6), the heart was stopped via cardioplegia (Kcl). T-PLS flow was maintained at 3.0-4.5 L/min. T-PLS functioned like a natural heart, having a pulse pressure of 26-43 mmHg and a pulse rate of 40-60 bpm (beats per minute). In the emergency case model (canine, N = 6), T-PLS was started 10 minutes after cardiac arrest from electronic shock. In spite of cardiac arrest for a period of 40 minutes, the heart was recovered after defibrillation. In the ARDS (Acute Respiratory Distress Syndrome) model (canine, N = 6), minimal ventilator parameters were set: tidal volume 130 ml, respiration rate = bpm, FiO2 = 10%. Three hours after starting T-PLS, PO2 of the carotid artery blood (after 2 hours: 195 +/- 89.4; after 3 hours: 258 +/- 99.3 mmHg) was above half the value of the femoral artery but was within normal range. CONCLUSION: It is suggested that a portable pulsatile ECLS like T-PLS may be used as a CPB device and as an alternative CPR (cardiopulmonary resuscitation) device in the case of cardiac arrest. Due to the pulsatile flow, oxygenated blood is delivered to the patient without overloading the ARDS patients heart.     

Prognostic factors of the long-term survival after transjugular intrahepatic portosystemic shunt in the treatment of gastric and esophageal variceal bleeding

Transjugular intrahepatic portosystemic shunt (TIPSS) is a promising method of treatment for gastric or esophageal variceal bleeding. This study was performed to determine the prognostic factors contributing to the survival of patients after TIPSS for gastric or esophageal variceal bleeding. One hundred and fifty-five patients who underwent TIPSS between September 1991 and March 2001 were followed up by clinical examination, upper gastrointestinal endoscopy, and Duplex sonography. The mean portohepatic pressure gradient prior to TIPSS was 20.5+/-9.93 mmHg and dropped to 10.7+/-6.62 mmHg after TIPSS (p<0.001). The cumulative survival rate was 75.1% at 6 months, 66.6% at 1 yr, 58.4% at 2 yr, and 38.1% at 5 yr. Survival after TIPSS was inversely related to the Child-Pugh classification (p<0.05). The rebleeding rate was 18.3% at 6 months, 21.0% at 1 yr, 32.8% at 2 yr, and 53.1% at 5 yr. The causes of deaths were hepatic failure (53.5%), recurrent variceal bleeding (11.6%), pneumonia (4.6%), sepsis (3.5%), hepatic encephalopathy (2.3%), and unknown (17.4%). Multivariate analysis (Cox proportional hazard model) revealed that the Child-Pugh classification and age were statistically significant independent prognostic factors. In conclusion, TIPSS is an effective method of treatment for variceal bleeding in cases where other treatment modalities including endoscopic therapy are unsuccessful and the most important prognostic factors are preprocedural hepatic reserve (Child-Pugh class) and age.     

Two-week, but not 1-week, hypoxic exposure enhances nitric oxide-mediated basal tone regulation in rat resistance pulmonary arteries

We measured internal diameter (ID) changes in resistance and conduit pulmonary arteries of 1- and 2-week hypoxic rats and normoxic control rats in response to nitric oxide synthase (NOS) inhibitors in vivo. At 2 weeks of hypoxic exposure, the ID reduction as a result of NOS inhibition was enhanced within the resistance arteries, but not at 1 week of hypoxia.     

HLA-A*0203-BSP的表达和复性及其四聚体的鉴定

目的：优化诱导条件大批量表达生物素化酶BirA底物肽（BSP）与HLA-A＊0203重链胞外域的融合蛋白（HLA—A＊0203、BSP），并制备负载HLA-A＊0203限制性EB病毒抗原肽EBNA3 596-604的四聚体（HIA—A}0203／SVR）。方法：以HLA—A＊0203-BSP原核表达载体转化E．coli BL21（DE3）菌株，优化诱导条件进行大批量重组蛋白的表达。通过稀释法复性可溶性HLA-A＊0203／SVR单体，然后以BirA对其进行生物素化，并以阴离子交换树脂纯化。将纯化的HLA-A＊0203／SVR单体与荧光素标记的链亲和素按4：1的比例混合形成四聚体，通过对特异性CTL进行染色验证其结合活性。结果：当IPTG的浓度为0．4mmol／L，于37℃诱导过夜后，融合蛋白的表达最多。该重组蛋白相对分子质量（Mr）为34003，与HLA—A＊0203-BSP的理论Mr相一致。该重组蛋白以包涵体形式存在于沉淀部分，约占菌体总蛋白的30％。负载抗原肽的可溶性HLA-A＊0203／SVR单体是在同时存在HLA-A＊0203，BSP、β2微球蛋白及HLA-A＊0203限制性抗原肽SVR的情况下通过稀释法复性而获得。该单体生物素化并纯化后与荧光素标记的链亲和素按4：1的比例混合后即形成四聚体。流式细胞术（FCM）分析证实，该四聚体具有与HLA—A2^＋供者特异性CTL结合的活性。结论：HLA—A＊0203-BSP融合蛋白在优化条件下获得高效表达。以此蛋白制备的HLA-A＊0203／SVR四聚体具有与HLA-A2^＋供者特异性CTL结合的活性，为研究HLA—A＊0203个体EB病毒特异性CTL的免疫应答打下了基础。     

定制化胫骨平台系统的构建及应用

为解决传统人工胫骨平台假体个体匹配性差，结构强度与生物活性难统一等问题，提出了定制化复合增强型人工胫骨平台系统的设计制造方法。采用解剖学建模技术设计出外形匹配，内含三维网状构架的复合假体模型，利用快速成型技术制造出假体的树脂原型，并分别通过精密铸造和粉末烧结技术制造出钛合金胫骨平台和大段多孔陶瓷人工骨。结果显示，该方法能快速而精确地制造出形状复杂的人工胫骨平台系统，是实现假体定制化制造的有利保证；通过将金属假体和多孔陶瓷人工骨复合，解决了载重部位大段骨缺损的修复问题。临床应用表明，该假体能与对侧关节匹配运动，通过将机械重建与生物重建相结合可实现受损关节的功能重建。     

小肠间质瘤的免疫组织化学特征其意义

目的探讨小肠间质瘤的临床病理诊断及免疫组织化学特征。方法收集我校附属医院临床病理科6年来对外科手术切除的小肠肿瘤标本,光镜观察、免疫组织化学方法检测Vimentin、desmin、S-100、actin、CD117、CD34和SMA的表达。结果13例肿瘤中良性3例,潜在恶性4例,恶性6例;其中黏膜下生长3例,浆膜下生长5例,肠系膜处生长2例,肌壁内生长3例,常见症状是上腹部肿块和上消化道出血,免疫表形特征为:CD11713例(100%)胞质阳性表达;CD3410例阳性(76.9%)表达,S-100蛋白2例(15.4%)呈局灶表达,10例SMA阴性表达。结论小肠间质瘤发生率较高,多为恶性,有必要和肠的雪旺细胞瘤、平滑肌瘤相区别,CD117、CD34可作为诊断小肠间质瘤免疫标记物,而肿瘤大小、有无出血和坏死、核分裂像等均可作为良恶之判断的参照指标。